DOOR Ranking
Cross-source consensus on DOOR Ranking from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Comparisons
Highlighted claims
- The primary outcome is a patient-centred DOOR hierarchical composite endpoint assessed at day 90. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial
- The DOOR hierarchy ranks survival as the most important outcome. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial
- Return to pre-infection functional level is the second priority in the DOOR hierarchy. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial
- Complications form the third DOOR component because patient representatives considered culture results and persistent, relapsing, or new infection highly relevant. — Linezolid in addition to standard antibiotic treatment for Staphylococcus aureus bacteraemia: study protocol for a randomised, placebo-controlled trial